Control group | Study group | p | |
Previous cytology | <0.001 | ||
Low grade | 42 (44.7%) | 39 (78.0%) | |
High grade | 52 (55.3%) | 11 (22.0%) | |
Previous HPV | 0.411 | ||
Others | 30 (30.6%) | 18 (39.1%) | |
16, 18, 45 | 68 (69.4%) | 28 (60.9%) | |
Lesion size | 0.102 | ||
1 - 2 quadrants | 82 (82.8%) | 47 (94.0%) | |
3 - 4 quadrants | 17 (17.2%) | 3 (6.0%) | |
Colposcopy findings | <0.001 | ||
Major changes | 50 (49.0%) | 41 (82.0%) | |
Minor changes | 52 (51.0%) | 9 (18.0%) | |
Previous biopsy | <0.001 | ||
CIN 2 | 16 (15.5%) | 32 (61.5%) | |
CIN 3 | 87 (84.5%) | 20 (38.5%) | |
Smoking habit | 0.467 | ||
Yes | 27 (31.0%) | 19 (38.8%) | |
No | 60 (69.0%) | 30 (61.2%) | |
Condon use | 0.867 | ||
Yes | 50 (53.2%) | 27 (56.2%) | |
No | 44 (46.8%) | 21 (43.8%) | |
Hormonal contraceptive | 0.005 | ||
Yes | 30 (37.0%) | 6 (12.5%) | |
No | 51 (63.0%) | 42 (87.5%) | |
Parity | 0.806 | ||
Nulliparous/Miscarriage | 70 (70.7%) | 35 (67.3%) | |
Pregnancy | 29 (29.3%) | 17 (32.7%) | |
Immunosuppression | 1.000 | ||
Yes | 2 (1.9%) | 1 (1.9%) | |
No | 101 (98.1%) | 51 (98.1%) | |
Age | 0.483 | ||
≤35 | 63 (61.2%) | 28 (53.8%) | |
>35 | 40 (38.8%) | 24 (46.2%) | |
Age | 0.187 | ||
≤40 | 86 (83.5%) | 38 (73.1%) | |
>40 | 17 (16.5) | 14 (26.9%) | |
Age | 0.098 | ||
≤50 | 101 (98.1) | 48 (92.3%) | |
>50 | 2 (1.9) | 4 (7.7%) | |
Cytology 6 months | 1.000 | ||
Negative | 97 (96.0%) | 50 (96.2%) | |
Positive | 4 (4.0%) | 2 (3.8%) |